Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01105611
Recruitment Status : Unknown
Verified March 2010 by St. James's Hospital, Ireland.
Recruitment status was:  Recruiting
First Posted : April 16, 2010
Last Update Posted : July 21, 2011
Information provided by:
St. James's Hospital, Ireland

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2012
  Estimated Study Completion Date : December 2012